OptimizeRx Corp. - רווח נקי למניה בארבעת הרבעונים האחרונים OPRX

High software switching costs and stringent data security regulations create a robust defensive moat for OptimizeRx Corporation (OPRX). The market trend of EPS value allows for tracking the dynamics of this advantage. The business relies on a scalable IT system for pharmaceutical companies with minimal capital expenditures, and the current figure is 17871.50. The model also promotes environmental sustainability by replacing paper-based documentation in clinics with digital services.

Year-over-year EPS (TTM) growth measures the dynamics of net income per share by comparing the current twelve-month period with the same period last year. This indicator reflects capital generation efficiency and business scaling rates. By analyzing the annual EPS TTM growth on the GURU.Markets platform, an investor can see the resilience of OptimizeRx Corporation (OPRX) to market fluctuations. The digitalization of healthcare smooths out the moderate cyclicality of marketing IT spending, supporting the stability of this fundamental metric.